Melville, New York, USA // Oxford, United Kingdom // Halle (Saale), Germany OSI Pharmaceuticals, Inc. (Nasdaq: OSIP), Prosidion Limited, a subsidiary of OSI focused on the […]
Status of opposition OF EP 0896538 During May 11-12, 2004, oral hearings were held at the European Patent Office in Munich concerning the oppositions filed against […]
Halle (Saale), Germany // Probiodrug AG conducted its 11th SAB meeting on December 12th and 13th to review in depth the company’s programs and focus. Prof. […]
Halle (Saale), Germany // Probiodrug AG, a private biotech company headquartered in Halle, Germany, announced today its expectation to have favorable results to report on its […]
Halle (Saale), Germany // Probiodrug announced today that the company has concluded a single dose clinical trial involving 16 patients. “A preliminary analysis of the data […]
Staatssekretär Maas: Biotechnologie ist Schwerpunktbranche in Sachsen-Anhalt Magdeburg, Halle (Saale), Germany // Der Innovationsbeauftragte der Landesregierung, Staatssekretär Manfred Maas, hat heute der Biotechnologiefirma Probiodrug AG einen […]
In a fruitful collaborative effort between the Max-Planck-Institute of Biochemistry, Proteros Biostructures GmbH, both located in Martinsried, and probiodrug AG, Halle (Saale), the sequence and 1.8 […]
Halle (Saale), Germany // Probiodrug demonstrates first long-term effect of DP IV inhibition in the treatment of type 2 diabetes: normalisation of fasting blood glucose and […]
Halle (Saale), Germany // Probiodrug AG announced today that the company has concluded its first in man dosing study of P93/01, its lead candidate to be […]